These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31600772)

  • 1. Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.
    Magliocco G; Rodieux F; Desmeules J; Samer CF; Daali Y
    Pediatr Res; 2020 Feb; 87(3):441-449. PubMed ID: 31600772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling.
    Upreti VV; Wahlstrom JL
    J Clin Pharmacol; 2016 Mar; 56(3):266-83. PubMed ID: 26139104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics.
    de Jong LM; Jiskoot W; Swen JJ; Manson ML
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33339226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics.
    Emoto C; Johnson TN
    Adv Pharmacol; 2022; 95():365-391. PubMed ID: 35953161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.
    Streetman DS; Bertino JS; Nafziger AN
    Pharmacogenetics; 2000 Apr; 10(3):187-216. PubMed ID: 10803676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
    Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
    Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.
    Magliocco G; Thomas A; Desmeules J; Daali Y
    Clin Pharmacokinet; 2019 Nov; 58(11):1373-1391. PubMed ID: 31131437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual Variability in Cytochrome P450-Mediated Drug Metabolism.
    Tracy TS; Chaudhry AS; Prasad B; Thummel KE; Schuetz EG; Zhong XB; Tien YC; Jeong H; Pan X; Shireman LM; Tay-Sontheimer J; Lin YS
    Drug Metab Dispos; 2016 Mar; 44(3):343-51. PubMed ID: 26681736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 polymorphism: From evolution to clinical use.
    Ingelman-Sundberg M
    Adv Pharmacol; 2022; 95():393-416. PubMed ID: 35953162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetics or "farm-ecogenetics"?].
    Gérard N; Elion J; Krishnamoorthy R
    J Soc Biol; 2000; 194(1):9-13. PubMed ID: 11107543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies as a probe in cytochrome P450 research.
    Shou M; Lu AY
    Drug Metab Dispos; 2009 May; 37(5):925-31. PubMed ID: 19196844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualizing the use of medications in children: making Goldilocks happy.
    Leeder JS; Brown JT; Soden SE
    Clin Pharmacol Ther; 2014 Sep; 96(3):304-6. PubMed ID: 24926777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Metabolic Phenotyping of Cytochrome Polymorphisms Using PubMed Abstract Mining.
    Chen L; Friedman C; Finkelstein J
    AMIA Annu Symp Proc; 2017; 2017():535-544. PubMed ID: 29854118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.
    Schwaiblmair M; Behr W; Foerg W; Berghaus T
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1547-60. PubMed ID: 22070131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy.
    Bechtold B; Clarke J
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):397-412. PubMed ID: 33339463
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.